Related Experiment Video
Updated: Jul 10, 2025

08:25
Identification of Circular RNAs using RNA Sequencing
Published on: November 14, 2019
12.3K
Circular RNAs: A New Approach to Multiple Sclerosis.
Raffaele Sciaccotta1, Giuseppe Murdaca2,3, Santino Caserta1
1Hematology Unit, Department of Human Pathology in Adulthood and Childhood "Gaetano Barresi", University of Messina, Via Consolare Valeria, 98125 Messina, Italy.
Biomedicines
|November 25, 2023
Summary
Circular RNAs (circRNAs) are newly identified non-coding RNAs impacting multiple sclerosis (MS) pathogenesis. Understanding their role in neuroinflammation and neuronal damage could revolutionize MS diagnostics and therapeutics.
Area of Science:
- Neuroimmunology
- Molecular Biology
- Genetics
Background:
- Multiple sclerosis (MS) involves central nervous system demyelination and axonal damage, driven by autoreactive immune cells targeting myelin antigens.
- Immune system dysregulation, including deficiencies and autoimmunity, can lead to disorders like MS.
- Non-coding RNAs (ncRNAs) are crucial regulators of gene expression and cellular functions, implicated in immune disorders.
Purpose of the Study:
- To review and investigate the role of circular RNAs (circRNAs), a class of ncRNAs, in the pathogenesis of multiple sclerosis (MS).
- To explore how circRNAs influence post-transcriptional regulation, gene expression, and epigenetic factors relevant to MS.
Main Methods:
- Literature review focusing on recent studies concerning circRNAs and their involvement in neuroimmune diseases.
- Analysis of the mechanisms by which circRNAs contribute to MS-specific pathologies.
Main Results:
- CircRNAs are shown to influence microRNA activity and epigenetic modifications, contributing to MS hallmarks.
- These circRNAs play a role in promoting neuroinflammation, neuronal cell damage, and microglial dysfunction in MS.
Conclusions:
- Increased knowledge of circRNAs in MS pathogenesis offers potential for novel diagnostic and therapeutic strategies.
- Understanding circRNAs may lead to a paradigm shift in viewing and managing this complex neuroimmune condition.
Related Concept Videos
siRNA - Small Interfering RNAs
16.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
RNA Interference
26.1K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.1K

